Health Canada
- Status: approved
🇨🇦 Evolocumab Auto-Injector [Repatha] in Canada
Evolocumab Auto-Injector [Repatha] (Evolocumab Auto-Injector [Repatha]) regulatory status in Canada.
Marketing authorisation
Evolocumab Auto-Injector [Repatha] in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Evolocumab Auto-Injector [Repatha] approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Evolocumab Auto-Injector [Repatha] in Canada?
Imperial College Healthcare NHS Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.